0001104659-22-030792.txt : 20220304
0001104659-22-030792.hdr.sgml : 20220304
20220304214339
ACCESSION NUMBER: 0001104659-22-030792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schlanger David J
CENTRAL INDEX KEY: 0001576145
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39100
FILM NUMBER: 22716079
MAIL ADDRESS:
STREET 1: C/O PROGYNY, INC.
STREET 2: 1359 BROADWAY, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Progyny, Inc.
CENTRAL INDEX KEY: 0001551306
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 272220139
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 212-888-3124
MAIL ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn, Inc.
DATE OF NAME CHANGE: 20150318
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn Inc
DATE OF NAME CHANGE: 20120601
4
1
tm228503-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-03-02
0
0001551306
Progyny, Inc.
PGNY
0001576145
Schlanger David J
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FL
NEW YORK
NY
10018
1
1
0
0
Executive Chairman
Common Stock
2022-03-02
4
M
0
50000
0.91
A
134000
D
Common Stock
2022-03-02
4
S
0
10885
42.73
D
123115
D
Common Stock
2022-03-02
4
S
0
5604
43.48
D
117511
D
Common Stock
2022-03-02
4
S
0
33511
44.51
D
84000
D
Common Stock
2022-03-03
4
M
0
50000
0.91
A
134000
D
Common Stock
2022-03-03
4
S
0
50000
43.67
D
84000
D
Employee Stock Option (Right to Buy)
0.91
2022-03-02
4
M
0
50000
0
D
2027-08-03
Common Stock
50000
1933680
D
Employee Stock Option (Right to Buy)
0.91
2022-03-03
4
M
0
50000
0
D
2027-08-03
Common Stock
50000
1883680
D
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.38 to $42.99, inclusive.
The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.91, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $44.83, inclusive.
One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date.
/s/ Jennifer Bealer, Attorney-in-Fact
2022-03-04